tradingkey.logo
搜尋

Oculis Holding AG

OCS
添加自選
11.979USD
+0.669+5.92%
收盤 07-31 16:00美東報價延遲15分鐘
703.03M總市值
虧損本益比TTM

關於 Oculis Holding AG 公司

Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Oculis Holding AG簡介

公司代碼OCS
公司名稱Oculis Holding AG
上市日期Mar 03, 2023
CEOSherif (Riad)
員工數量49
證券類型Ordinary Share
年結日Mar 03
公司地址Bahnhofstrasse 20
城市ZUG
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Switzerland
郵編6300
電話41417113960
網址https://oculis.com/
公司代碼OCS
上市日期Mar 03, 2023
CEOSherif (Riad)

Oculis Holding AG公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--
Dr. Riad Sherif, M.D.
Dr. Riad Sherif, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Anthony A. (Tony) Rosenberg
Mr. Anthony A. (Tony) Rosenberg
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Arshad M. Khanani, M.D.
Mr. Arshad M. Khanani, M.D.
Independent Director
Independent Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Martijn Kleijwegt
Mr. Martijn Kleijwegt
Independent Director
Independent Director
470.97K
--
Mr. Pall Ragnar Johannesson
Mr. Pall Ragnar Johannesson
Chief Business Officer
Chief Business Officer
288.43K
+6.80%
Mr. Lionel Carnot
Mr. Lionel Carnot
Independent Director
Independent Director
90.75K
--
Ms. Sylvia Cheung, CPA
Ms. Sylvia Cheung, CPA
Chief Financial Officer
Chief Financial Officer
77.32K
+6.80%
Ms. Geraldine O'Keeffe
Ms. Geraldine O'Keeffe
Independent Director
Independent Director
20.59K
--
Ms. Christina M. Ackermann
Ms. Christina M. Ackermann
Independent Director
Independent Director
6.53K
--

常見問題

Oculis Holding AG的前五大股東是誰?

Oculis Holding AG的前五大股東如下:Mr. Martijn Kleijwegt

有多少機構持有Oculis Holding AG(OCS)的股份?

截至2026Q1,共有72家機構持有Oculis Holding AG的股份,合計持有的股份價值約為27.88M,占公司總股份的54.68% 。與2025Q4相比,機構持股有所增加,增幅為2538023.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有